The stock surged 20% to Rs 239 on the NSE in early morning trade on Monday, rallying 43% in past two trading sessions.
The stock is locked in upper circuit of 20% at Rs 206 on the BSE after the US health regulator cleared inspection of the company's Goa plant II & III with two minor observations.
The stock tanked 16% to Rs 208.50, also its 52-week low on the NSE in early morning trade
The stock up 6% to Rs 349 after the company announced it has acquired the manufacturing facility of Micro Labs located at Baddi.
The moved higher by 15% to Rs 305 on the BSE.
The stock has rallied 19% to Rs 314 after the company received USFDA approval for Goa solid dosages plant